Page not found

Search results

  1. From Concept to Commercialization: Dr. Paul Yock

    ... for Biodesign, dedicated to advanced training in medical technology innovation. Join us for an open discussion with Dr. Yock on biodesign, medical technology innovation, and his entrepreneurial journey. Registration is ...

    sommers - 04/19/2024 - 9:21am

  2. LaunchTN, Vanderbilt partner to support innovation, commercialization of Tennessee-based technologies

    ... solutions to market with increased activities around technology transfer and commercialization. Vanderbilt, a world-renowned ... Vanderbilt’s Innovation Center , and the  Center for Technology Transfer and Commercialization  — made the collaborative ...

    sommers - 05/11/2023 - 9:10am

  3. Bifunctional Small Molecule Compound Technology that Modulates Protein-Protein Interactions

    When:  Sunday, March 31, 2024 - 12:00am Daiichi Sankyo is looking for bifunctional small molecules that can inhibit target protein function through protein-protein interactions (PP...

    cttc_admin - 03/14/2024 - 6:09pm

  4. Vanderbilt and Deerfield Management celebrate Ancora Innovation, a collaboration for accelerating drug discovery, potential life-changing therapeutics

    ... cures for patients.” Vanderbilt’s Center for Technology Transfer and Commercialization within the Office of the Vice Provost ... the guidance and support of  Assistant Vice Chancellor for Technology Transfer and Intellectual Property Development Alan Bentley  and  ...

    sommers - 03/03/2023 - 1:30pm

  5. Center for Technology Transfer and Commercialization breaks records in leveraging innovation and discovery at Vanderbilt

    ... 10/10/2022 The  Vanderbilt Center for Technology Transfer and Commercialization  generated more than $100 million ... basis) is the largest annual amount generated through technology licensing since CTTC’s establishment in 1991 and greater than the ...

    sommers - 10/10/2022 - 10:35am

  6. Immunotherapies linked to specific heart complications

    ... of immunotherapies. The researchers used VigiBase, a global database of drug complications maintained by the World Health Organization, to ... the hope of utilizing Vanderbilt resources like the REDCap database to track these toxicities. In addition, the group has established a ...

    sommers - 02/21/2019 - 9:51am

  7. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  8. Study tracks incidence, timing of immunotherapy-related deaths

    ... drug reaction reports in a World Health Organization (WHO) database searching for those related to immune checkpoint inhibitors. They also ... more than 16 million reports in the WHO pharmacovigilance database (Vigilyze) from 2009 to 2018. Myocarditis (inflammation of the heart) ...

    sommers - 02/21/2019 - 9:51am

  9. How to Start a University Spinoff Biotech: From Concept to Commercialization

    ... Family Center for Applied Innovation and the Center for Technology Transfer & Commercialization present the next presentation from the ... (CCIV). He developed an RSV reverse genetics platform technology and novel strategies and methods for making vaccine candidates by ...

    sommers - 04/03/2023 - 12:32pm

  10. Center for Technology Transfer and Commercialization, partners launch Vanderbilt Innovation Ambassadors Program

    ... effort of the School of Medicine, VUMC and the Center for Technology Transfer and Research. Its goal is to serve the entire Vanderbilt ... research assistant professor Adam Yock , director of technology and innovation and assistant professor of radiation oncology ...

    sommers - 10/14/2022 - 10:06am